Sanofi

Bringing out the best in people at Sanofi

September 20, 2021 | 09:00

Driven by people-centric business administration, Sanofi is bringing out the best in its people and helping improve people’s accessibility to vaccines worldwide.

Sanofi’s ambition to empower lives

April 26, 2021 | 15:00

Amid the continuous development of COVID-19 globally, French drugmaker Sanofi is seeking to fulfil its ambition of empowering people this year and beyond.

Popular pharma products withdrawn by multinationals

December 10, 2020 | 10:00

Multinationals like Sanofi, GSK, Adamed Pharma, and Merck Sharp & Dohme have requested marketing authorisation withdrawal of some pharmaceuticals, with it being unclear if the quality of some popular items is an underlying issue.

Digitalisation prompts evolution of healthcare

September 04, 2020 | 15:00

Burning to take advantage of Vietnam’s new digital transformation in the healthcare sector, international pharma giants like Novartis, AstraZeneca, Sanofi, and GSK are working to align with the new requirements and obtain sustainable gains.

Vaccine sales stir big pharma

August 13, 2020 | 08:00

Amidst lower-than-expected business performance, international pharma giants are betting on COVID-19 vaccine sales, hoping to alter the headwinds from the health crisis to their advantage.

Sanofi makes second run for EU-GMP recognition

July 08, 2020 | 09:00

Amid ongoing revision of the regulation of drug tenders at public hospitals, multinational corporations are renewing efforts to have EU-GMP standards for their manufacturing sites acknowledged in Vietnam to qualify for the most lucrative tenders.

Sanofi eyes approval of COVID-19 vaccine by first half of 2021

June 24, 2020 | 08:51

PARIS: French drugmaker Sanofi said on Tuesday (Jun 23) it expects to get approval for the potential COVID-19 vaccine it is developing with Britain's GlaxoSmithKline by the first half of next year, faster than previously anticipated.

Pharma groups to profit from virus?

May 19, 2020 | 10:10

The top 10 global pharmaceutical companies are being scrutinised and advised not to prevent or delay a vaccine for COVID-19 from reaching vulnerable people to gain profits, triggering global concerns over their social responsibility.

Global virus vaccine race heats up, but not without controversy

May 15, 2020 | 16:30

Global tensions simmered over the race for a coronavirus vaccine on Thursday, as the United States and China traded jabs, and France slammed pharmaceuticals giant Sanofi for suggesting the US would get any eventual vaccine first.

Multinationals riding high in Vietnam’s pharma landscape

May 15, 2020 | 10:00

Multinational corporations like Sanofi, GlaxoSmithKline, and Reckitt Benckiser gaining the advantage in Vietnam’s over-the-counter channel, or non-description drugs, in the first quarter of 2020 has in part fuelled their global performance.

Global pharma groups push on with operations

April 02, 2020 | 08:00

Despite having risk management solutions to ensure drug import continuity to Vietnam in response to EU border closures, international pharma giants Sanofi, Zuellig Pharma, Adamed, and Novartis are closely monitoring the situation due to the potential direct impacts on long-term supply security.